Drug Interactions and Precautions

Introduction to Fluconazole and Sulfasalazine Interaction

Fluconazole is a potent inhibitor of the cytochrome P450 enzymes, particularly CYP2C9 and CYP2C19, which can affect the metabolism of sulfasalazine, potentially leading to increased serum levels of sulfasalazine and its metabolites, enhanced risk of adverse effects from both medications, and prolonged half-life of sulfasalazine, as supported by the American Academy of Dermatology 1
The combined use of fluconazole and sulfasalazine may increase the risk of hepatotoxicity due to the inhibition of hepatic enzymes that metabolize sulfasalazine by fluconazole, with a strength of evidence based on pharmacokinetic interactions 1

Patients on fluconazole and sulfasalazine should be monitored with complete blood count with differential, liver function tests, chemistry panel, and renal function tests to detect potential hepatotoxicity and other adverse effects, as recommended by the American Academy of Dermatology 1
Monitoring for signs of hepatotoxicity, such as jaundice, right upper quadrant pain, and fatigue, as well as hematologic abnormalities, including unusual bleeding, bruising, and pallor, is crucial when combining fluconazole and sulfasalazine, with a high strength of evidence for this recommendation 1

Consider alternative medications, adjust dosing of sulfasalazine, and provide folate supplementation to minimize risks associated with the combined use of fluconazole and sulfasalazine, as suggested by the American Academy of Dermatology, although the strength of evidence for these specific measures is not provided 1
Ensuring adequate hydration and educating patients about potential side effects and when to seek medical attention are key components of patient management on fluconazole and sulfasalazine, with a moderate strength of evidence for these recommendations 1

Patients with a history of sulfonamide allergy should be carefully evaluated for the risk-benefit ratio of using sulfasalazine due to potential cross-reactivity, as noted by the American Academy of Dermatology, with a moderate strength of evidence for this consideration 1
Sulfasalazine has an FDA pregnancy category B rating, and fluconazole may pose risks in pregnancy, especially at high doses, highlighting the need for careful consideration in pregnant patients, based on general principles of drug safety in pregnancy, with a high strength of evidence for these considerations 1
Sulfasalazine can cause significant side effects, including gastrointestinal symptoms, hematologic abnormalities, and various drug interactions, requiring careful monitoring and management, as reported by the American Academy of Dermatology and Gastroenterology 2, 3
The following medications and substances may interact with sulfasalazine:

Recommended monitoring tests include:

Test	Frequency
Complete blood count (CBC) with differential	Weekly for the first month, every 2 weeks for the next 2 months, and monthly thereafter
Liver function tests	Monthly
Chemistry panel	Monthly
Pregnancy test	If indicated
Urinalysis and renal function tests	Periodically

Folate supplementation is recommended to prevent megaloblastic anemia, with a high strength of evidence for this recommendation, as noted in Gastroenterology 3